Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
STOCKS
A Neurotrope Stock Promotion Scheme Is Underway, but Who's Paying for It?
By Adam Feuerstein
May 3, 2017 2:58 PM EDT
PRESS RELEASES
Neurotrope And Metuchen Pharmaceuticals Announce Completion Of Merger Forming Petros Pharmaceuticals
By PR Newswire
Dec 2, 2020 9:00 AM EST
PRESS RELEASES
Neurotrope, Inc. Approves Spin-Off Of Neurotrope Bioscience, Inc. And Sets Record And Distribution Dates
By PR Newswire
Nov 20, 2020 9:00 AM EST
PRESS RELEASES
Neurotrope Announces First Patient Dosed In Long-Term Clinical Trial Of Bryostatin In Alzheimer's Disease
By PR Newswire
Oct 6, 2020 9:00 AM EDT
PRESS RELEASES
Neurotrope Bioscience Announces Agreement With Worldwide Clinical Trials, To Conduct Ongoing Phase 2 Study Of Bryostatin-1, Partially Funded By NIH, For Alzheimer's Disease
By PR Newswire
Jul 30, 2020 9:00 AM EDT
PRESS RELEASES
Neurotrope Announces Strategic Partnership With BryoLogyx For Supply Of Synthetic Bryostatin-1 And Continuation Of The National Cancer Institute (NCI) Trial For Childhood Leukemia
By PR Newswire
Jun 10, 2020 8:41 AM EDT
PRESS RELEASES
Neurotrope Launches New Long-Term Clinical Trial Of Bryostatin With The National Institutes Of Health For The Treatment Of Patients With Alzheimer's Disease
By PR Newswire
May 28, 2020 9:00 AM EDT
PRESS RELEASES
Neurotrope Announces Investor Update Conference Call
By PR Newswire
May 26, 2020 4:20 PM EDT
PRESS RELEASES
Neurotrope And Metuchen Pharmaceuticals Announce Merger Agreement To Form Petros Pharmaceuticals, A Men's Health Company
By PR Newswire
May 18, 2020 8:45 AM EDT
PRESS RELEASES
Neurotrope, Inc. Announces $18 Million Registered Direct Offering
By PR Newswire
Jan 22, 2020 2:05 PM EST
PRESS RELEASES
Neurotrope Provides Corporate Update After Completing Bryostatin-1 Data Analysis For Advanced Alzheimer's Disease Trial
By PR Newswire
Jan 22, 2020 9:00 AM EST
STOCKS
A Neurotrope Stock Promotion Scheme Is Underway, but Who's Paying for It?
By Adam Feuerstein
May 3, 2017 2:58 PM EDT
FUTURES
Tech Leads Nasdaq to New Records, Congress Deal Boosts S&P 500
By Keris Alison Lahiff
May 1, 2017 4:17 PM EDT
FUTURES
Stocks Trade Higher, Financial Stocks on Watch
By Keris Alison Lahiff
May 1, 2017 2:40 PM EDT
FUTURES
Stocks Move Higher, Nasdaq at Records as Congress Makes Funding Deal
By Keris Alison Lahiff
May 1, 2017 11:09 AM EDT
FUTURES
Stock Futures Climb After Congress Reaches Funding Deal to Avoid Government Shutdown
By Keris Alison Lahiff
May 1, 2017 8:39 AM EDT
STOCKS
Neurotrope Spins a Failed Alzheimer's Drug Study
By Adam Feuerstein
May 1, 2017 7:18 AM EDT
STOCKS
Biotech Stock Mailbag: Sage Therapeutics, Cellceutix, Alzheimer's Risk
By Adam Feuerstein
Mar 24, 2017 8:34 AM EDT
STOCKS
Neurotrope Shares Soar as Alzheimer's Drug Trial Lottery Ticket Call Nears
By Adam Feuerstein
Mar 13, 2017 12:51 PM EDT
